17S U2 snRNP: Difference between revisions
From Proteopedia
Jump to navigationJump to search
Ananya Datta (talk | contribs) New page: ==PDB ID - 6Y5Q== <StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> This is a default text for your page '''Human 17S U2 small nuclear ri... |
Ananya Datta (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
==PDB ID - 6Y5Q== | ==PDB ID - 6Y5Q== | ||
<StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> | <StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> | ||
The 17S U2 small nuclear ribonucleoprotein (snRNP) is a critical precursor complex in pre-mRNA splicing, primarily responsible for recognizing the intron branch-site adenosine (BS-A). Its structure is highly regulated, defining a pre-catalytic state that must undergo significant remodelling for splicing to occur. | The 17S U2 small nuclear ribonucleoprotein (snRNP) is a critical precursor complex in pre-mRNA splicing, primarily responsible for recognizing the intron branch-site adenosine (BS-A). Its structure is highly regulated, defining a pre-catalytic state that must undergo significant remodelling for splicing to occur. | ||
| Line 31: | Line 27: | ||
•Conformational Switch: Release of the BSL allows the U2 5′ region to rotate and form the extended U2–BS helix. This pairing and the subsequent docking of the BS-A trigger the SF3B1 HEAT domain to close around the U2–BS helix, forming a critical pocket that locks the complex into the active state (A B complex transition). | •Conformational Switch: Release of the BSL allows the U2 5′ region to rotate and form the extended U2–BS helix. This pairing and the subsequent docking of the BS-A trigger the SF3B1 HEAT domain to close around the U2–BS helix, forming a critical pocket that locks the complex into the active state (A B complex transition). | ||
•SF3B1 and Cancer: SF3B1 is a common mutational target in haematopoietic cancers. Many cancer-associated SF3B1 mutations cluster near HR6, adjacent to PRP5-interacting regions, suggesting these mutations may disrupt the crucial PRP5 binding and RNP remodeling steps, leading to splicing defects implicated in disease. | •SF3B1 and Cancer: SF3B1 is a common mutational target in haematopoietic cancers. Many cancer-associated SF3B1 mutations cluster near HR6, adjacent to PRP5-interacting regions, suggesting these mutations may disrupt the crucial PRP5 binding and RNP remodeling steps, leading to splicing defects implicated in disease. | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 10:32, 30 November 2025
PDB ID - 6Y5Q
| ||||||||||||